Concepedia
Statistics
Publications
14
Citations
673
H-Index
Active since
2013
Affiliations
Emory University(Current)
Beijing Friendship Hospital
Capital Medical University
Winship Cancer Institute
Central South University
Weilong Yao is an author at Emory University specializing in oncology, molecular oncology, and apoptosis.
Publications per year
2013–2022
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment
Puyu Shi, You-Take Oh, Guojing Zhang et al. · Cancer Letters · 2016 · 182 citations
Medicine, Molecular Biology, Oncology +14
BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1
Dan Zong, Jiajia Gu, Giovanna C. Cavalcante et al. · Cancer Research · 2020 · 77 citations
Medicine, Molecular Biology, Oncology +15
Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells
Weilong Yao, Ping Yue, Guojing Zhang et al. · Cancer Letters · 2015 · 52 citations
Life Sciences, Oncology, Pharmacology +16
KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis
Weilong Yao, Yue Jiao, Yanhua Zhou et al. · Cell & Bioscience · 2020 · 51 citations · Full text
Medicine, Molecular Biology, Oncology +13
MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3
Shihua Qin, Yanjing Zhu, Fujun Ai et al. · Neoplasma · 2013 · 47 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 14